BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, June 7, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 24, 2009
View Archived Issues
Veltuzumab active at low doses in recurrent non-Hodgkin's lymphoma
Read More
Abeta1-15 vaccine ACI-24 shows positive safety profile in a mouse model of AD
Read More
Optimized formulation of Pronucleon peptides developed as an in vitro diagnostic tool for AD
Read More
Oral formulations of TBR-652 evaluated in healthy volunteers
Read More
ABT-089 reverses scopolamine-induced cognitive deficits in healthy volunteers
Read More
Novartis reports first results for the first half of 2009
Read More
YM-254890 shows potent bronchodilator activity in rodent models
Read More
Bristol-Myers acquires Medarex, thereby gaining rights to ipilimumab
Read More
Merck submits MAA for cladribine tablets for multiple sclerosis in Europe
Read More
Nabriva initiates phase I trial for pleuromutilin antibiotic, BC-3781
Read More
PharmaMar commences phase II Zalypsis trial in endometrial and cervical cancer
Read More
Schering-Plough files NDA for mometasone/formoterol combination for asthma
Read More
Taiho receives approval for TS-1 in Singapore
Read More
Theravance patents muscarinic receptor antagonists for the treatment of COPD and asthma
Read More
Novel PI3K inhibitors claimed by UCB for the treatment of cancer
Read More
Janssen discovers novel CB2 receptor agonists for the treatment of pain
Read More
Alcon and AstraZeneca collaborate on ophthalmic drug discovery
Read More
Takeda provides update on fixed-dose combination of alogliptin and Actos
Read More
GlaxoSmithKline completes acquisition of Stiefel
Read More
Regeneron enrolls first patient in phase III VEGF Trap-Eye program in CRVO
Read More
GSK and Enigma sign commercial partnership to develop influenza diagnostics
Read More
Peplin initiates final phase III PEP-005 gel trial in actinic keratoses
Read More
Kyowa Hakko Kirin reports results from phase III trial KW-2246 trial
Read More
AcelRx reports results from phase II study of ARX-01 Sufentanil NanoTab PCA system
Read More
Galapagos receives milestone payment under osteoporosis collaboration with Lilly
Read More
